| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |